TLDR:
– Insilico Medicine launches DORA, an AI assistant for drafting medical research papers.
– DORA helps early-career researchers and non-native English speakers by supporting the drafting of academic papers, case studies, grant applications, and patents.
– DORA incorporates multiple AI models and requires human proofreading for accuracy.
– Insilico is also developing offline servers for data privacy and launching an open-source AI program for research into aging and related diseases.
Key Elements:
Insilico Medicine, known for its generative AI in drug discovery, is now offering an AI assistant named DORA to help researchers draft medical papers. The goal is to support early-career researchers and non-native English speakers in contributing to medical research.
DORA uses multiple AI models to generate drafts but still requires human proofreading for accuracy. Insilico is also addressing data privacy concerns by developing offline servers for secure analysis.
In addition to DORA, Insilico is launching an open-source AI program called Precious-3 GPT for research into aging and related diseases. This program aims to predict factors such as drug sensitivity and cellular interactions, considering the aging process at a molecular level.